title: A survey of a novel epilepsy clinic.
abstract: The management of a group of epilepsy patients from primary care, in a geographical area with clear epilepsy management guidelines and secondary care clinics is surveyed. Suggestions are made to improve liaison between primary and secondary care as well as epilepsy management in primary care. All 42 local primary care practices were invited to take part in this project. A study day providing a broad overview of epilepsy management was held. Those attending were expected to identify all patients in their practice with epilepsy using diagnostic codes and prescribing data. Nine of the invited 42 practices took part in the project, and identified 506 patients prescribed anti-epilepsy drugs (AEDs). Three hundred and three patients were invited for review by their practice nurse, following exclusion of those prescribed AEDs for other conditions, children and those already under specialist review. One hundred and sixteen patients attended for review. Seventy-one patients were identified as requiring specialist review and a consultant neurologist, epilepsy nurse specialist and clinical assistant completed them. Of the 71 patients 31 had experienced no seizures for 5 years, 40 had experienced seizures in the past 5 years, of whom 32 had experienced seizures in the last year. Sixteen were suffering at least one seizure per month, and a few had poorly controlled epilepsy. Patients were taking mainly Phenytoin, Carbamazepine and Sodium valproate. Twenty were taking polytherapy and one no treatment.Fifty-two patients reported side effects and 15 poor compliance. Many patients reviewed were considered to be taking unnecessary medication and suffering unnecessary side effects. There is a need for improved epilepsy management in primary care and better liaison between primary and secondary care.
authors.affiliation: Department of Neurology, Northampton General Hospital NHS Trust, Cliftonville, Northampton, UK. mel.goodwin@ngh-tr.anglox.nhs.uk
authors.forename: Mel
authors.initials: M
authors.lastname: Goodwin
authors.forename: David
authors.initials: D
authors.lastname: Wade
authors.forename: Barbara
authors.initials: B
authors.lastname: Luke
authors.forename: Paul
authors.initials: P
authors.lastname: Davies
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D019091:Critical Pathways; D004359:Drug Therapy, Combination; D004739:England; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006782:Hospitals, Special; D006801:Humans; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D009720:Nurse Clinicians; D010348:Patient Care Team; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D012017:Referral and Consultation
chemical_list: D000927:Anticonvulsants